Ubs Oconnor LLC Haleon PLC Transaction History

Ubs Oconnor LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$7.78 - $8.62 $409,889 - $454,144	-52,685 Reduced 71.02%	21,500 $176,000
Q3 2023 Nov 14, 2023	SELL	$7.85 - $8.94 $1.41 Million - $1.61 Million	-180,000 Reduced 70.81%	74,185 $617,000
Q2 2023 Aug 14, 2023	BUY	$8.04 - $9.0 $2.04 Million - $2.29 Million	254,185 New	254,185 $2.13 Billion
Q1 2023 May 15, 2023	BUY	$7.57 - $8.37 $87,115 - $96,321	11,508 Added 5.0%	241,662 $1.97 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.06 $276,186 - $373,500	46,340 Added 25.21%	230,154 $0
Q3 2022 Nov 14, 2022	BUY	$5.63 - $7.5 $1.03 Million - $1.38 Million	183,814 New	183,814 $1.12 Billion

663

417M

269K

40.6K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $46.6B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.